Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dean A Regier

Showing results (81-90 of 124) with videos related to

Pageof 13
Sort By:
MDM Policy & Practice|June 28, 2019
The EORTC QLU-C10D: The Canadian Valuation Study and Algorithm to Derive Cancer-Specific Utilities From the EORTC QLQ-C30Helen McTaggart-Cowan, Madeleine T King, Richard Norman, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 23, 2013
Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task ForceF Reed Johnson, Emily Lancsar, Deborah Marshall, et al.
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|August 24, 2023
Evaluation of the Association Between Sociodemographic Status and Breast Screening Volumes During the COVID-19 Pandemic in a Provincial, Population-Based Organized Breast Screening ProgramHelena Bentley, Nivedha Raveinthiranathan, Colin Mar, et al.
NPJ Precision Oncology|October 25, 2022
A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in CanadaDean A Regier, Samantha Pollard, Melanie McPhail, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 22, 2020
Health-care practitioners' preferences for the return of secondary findings from next-generation sequencing: a discrete choice experimentShan Jiang, Aslam H Anis, Ian Cromwell, et al.
Plos One|October 20, 2012
Discrete choice experiment to evaluate factors that influence preferences for antibiotic prophylaxis in pediatric oncologyDean A Regier, Caroline Diorio, Marie-Chantal Ethier, et al.
Current Oncology (Toronto, Ont.)|September 30, 2021
The Past, Present, and Future of Economic Evaluations of Precision Medicine at the Committee for Economic Analyses of the Canadian Cancer Trials GroupKelvin K W Chan, Matthew C Cheung, Dean A Regier, et al.
Lancet Regional Health. Americas|November 28, 2024
Real-world cost-effectiveness of multi-gene panel sequencing to inform therapeutic decisions for advanced non-small cell lung cancer: a population-based studyEmanuel Krebs, Deirdre Weymann, Cheryl Ho, et al.
Cancers|February 25, 2022
Cost-Effectiveness of Molecularly Guided Treatment in Diffuse Large B-Cell Lymphoma (DLBCL) in Patients under 60Dean A Regier, Brandon Chan, Sarah Costa, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 1, 2013
Return of incidental findings in genomic medicine: measuring what patients value--development of an instrument to measure preferences for information from next-generation testing (IMPRINT)Caroline Savage Bennette, Susan Brown Trinidad, Stephanie M Fullerton, et al.
Pageof 13

Showing results (81-90 of 124) with videos related to

Sort By:
Pageof 13
MDM Policy & Practice|June 28, 2019
The EORTC QLU-C10D: The Canadian Valuation Study and Algorithm to Derive Cancer-Specific Utilities From the EORTC QLQ-C30Helen McTaggart-Cowan, Madeleine T King, Richard Norman, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 23, 2013
Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task ForceF Reed Johnson, Emily Lancsar, Deborah Marshall, et al.
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|August 24, 2023
Evaluation of the Association Between Sociodemographic Status and Breast Screening Volumes During the COVID-19 Pandemic in a Provincial, Population-Based Organized Breast Screening ProgramHelena Bentley, Nivedha Raveinthiranathan, Colin Mar, et al.
NPJ Precision Oncology|October 25, 2022
A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in CanadaDean A Regier, Samantha Pollard, Melanie McPhail, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 22, 2020
Health-care practitioners' preferences for the return of secondary findings from next-generation sequencing: a discrete choice experimentShan Jiang, Aslam H Anis, Ian Cromwell, et al.
Plos One|October 20, 2012
Discrete choice experiment to evaluate factors that influence preferences for antibiotic prophylaxis in pediatric oncologyDean A Regier, Caroline Diorio, Marie-Chantal Ethier, et al.
Current Oncology (Toronto, Ont.)|September 30, 2021
The Past, Present, and Future of Economic Evaluations of Precision Medicine at the Committee for Economic Analyses of the Canadian Cancer Trials GroupKelvin K W Chan, Matthew C Cheung, Dean A Regier, et al.
Lancet Regional Health. Americas|November 28, 2024
Real-world cost-effectiveness of multi-gene panel sequencing to inform therapeutic decisions for advanced non-small cell lung cancer: a population-based studyEmanuel Krebs, Deirdre Weymann, Cheryl Ho, et al.
Cancers|February 25, 2022
Cost-Effectiveness of Molecularly Guided Treatment in Diffuse Large B-Cell Lymphoma (DLBCL) in Patients under 60Dean A Regier, Brandon Chan, Sarah Costa, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 1, 2013
Return of incidental findings in genomic medicine: measuring what patients value--development of an instrument to measure preferences for information from next-generation testing (IMPRINT)Caroline Savage Bennette, Susan Brown Trinidad, Stephanie M Fullerton, et al.
Pageof 13